Login Register Cart 0
Generic placeholder image

Reviews on Recent Clinical Trials

Editor-in-Chief

ISSN (Print): 1574-8871
ISSN (Online): 1876-1038

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Review Article

Radiation-Induced Oral Mucositis in Head and Neck Cancer Patients. Five Years Literature Review

Author(s): Areti Gkantaifi*, Emmanouil Vardas, Filippo Alongi, Nikolaos Tsoukalas, Haytham Hamed Saraireh, Nikolaos Charalampakis, Jozsef Lövey, Jiannis Hajiioannou, Efthymios Kyrodimos, Konstantinos Tsanadis, Davide Mauri, Christos Christopoulos, George Iliadis and Maria Tolia

Volume 16, Issue 2, 2021

Published on: 31 July, 2020

Page: [151 - 165] Pages: 15

DOI: 10.2174/1574887115666200731182708

Price: $65

Abstract

Backround: Radiation-induced oral mucositis consists of a series of relatively frequent side effects after head and neck cancer radiotherapy and has an adverse impact on both regular treatment process and the quality of life of patients.

Objective: The purpose of the present review is to optimize the current management of radiation-induced oral mucositis in head and neck cancer patients.

Methods: PubMed database research was performed on articles published since 2015 that demonstrated efficacy in the management of radiation-induced oral mucositis in head and neck cancer patients. The study selection included observational, prospective, comparative, randomized, double- blind, placebo-controlled or uncontrolled, and retrospective studies, as well as systematic reviews and metanalyses.

Results: From the 931 citations obtained from the search, only 94 articles met the inclusion criteria, including mucosal protectants, anti-inflammatory agents, growth factors, and various miscellaneous and natural agents. Several methods, including both pharmacological and natural agents, have been proposed for the management of oral mucositis. In addition to the already known interventions with strong evidence, according to the Multinational Association of Supportive Care in Cancer and he International Society of Oral Oncology guidelines, further agents have been used. However, a great number of them lack clear evidence, which surely requires the design of more controlled clinical trials for a better assessment of the ideal methods.

Conclusion: The management of oral mucositis constitutes an active area of research. In light of these results, it is aimed to illustrate those treatment strategies that are most effective regarding the treatment approach of oral mucositis.

Keywords: Oral mucositis, radiotherapy, head and neck cancer, interventions, prevention, treatment.

« Previous Next »
Graphical Abstract

[1]
Gatta G, Botta L, Sánchez MJ, Anderson LA, Pierannunzio D, Licitra L. Prognoses and improvement for head and neck cancers diagnosed in Europe in early 2000s: The EUROCARE-5 population-based study. Eur J Cancer 2015; 51(15): 2130-43.
[http://dx.doi.org/10.1016/j.ejca.2015.07.043] [PMID: 26421817]
[2]
Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 2018; 68(6): 394-424.
[http://dx.doi.org/10.3322/caac.21492] [PMID: 30207593]
[3]
Bray F, Ren JS, Masuyer E, Ferlay J. Global estimates of cancer prevalence for 27 sites in the adult population in 2008. Int J Cancer 2013; 132(5): 1133-45.
[http://dx.doi.org/10.1002/ijc.27711] [PMID: 22752881]
[4]
Znaor A, Brennan P, Gajalakshmi V, et al. Independent and combined effects of tobacco smoking, chewing and alcohol drinking on the risk of oral, pharyngeal and esophageal cancers in Indian men. Int J Cancer 2003; 105(5): 681-6.
[http://dx.doi.org/10.1002/ijc.11114] [PMID: 12740918]
[5]
Chaturvedi AK, Engels EA, Pfeiffer RM, et al. Human papillomavirus and rising oropharyngeal cancer incidence in the United States. J Clin Oncol 2011; 29(32): 4294-301.
[http://dx.doi.org/10.1200/JCO.2011.36.4596] [PMID: 21969503]
[6]
Ang KK, Harris J, Wheeler R, et al. Human papillomavirus and survival of patients with oropharyngeal cancer. N Engl J Med 2010; 363(1): 24-35.
[http://dx.doi.org/10.1056/NEJMoa0912217] [PMID: 20530316]
[7]
Friedland PL, Bozic B, Dewar J, Kuan R, Meyer C, Phillips M. Impact of multidisciplinary team management in head and neck cancer patients. Br J Cancer 2011; 104(8): 1246-8.
[http://dx.doi.org/10.1038/bjc.2011.92] [PMID: 21448166]
[8]
Pignon JP, le Maître A, Maillard E, Bourhis J. MACH-NC Collaborative Group. Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): an update on 93 randomised trials and 17,346 patients. Radiother Oncol 2009; 92(1): 4-14.
[http://dx.doi.org/10.1016/j.radonc.2009.04.014] [PMID: 19446902]
[9]
Ko C, Citrin D. Radiotherapy for the management of locally advanced squamous cell carcinoma of the head and neck. Oral Dis 2009; 15(2): 121-32.
[http://dx.doi.org/10.1111/j.1601-0825.2008.01495.x] [PMID: 19036056]
[10]
Vera-Llonch M, Oster G, Hagiwara M, Sonis S. Oral mucositis in patients undergoing radiation treatment for head and neck carcinoma. Cancer 2006; 106(2): 329-36.
[http://dx.doi.org/10.1002/cncr.21622] [PMID: 16342066]
[11]
He M. HeM. Interventions for preventing oral mucositis in patients with cancer receiving treatment. Clin Nurse Spec 2011; 25(6): 284-5.
[http://dx.doi.org/10.1097/NUR.0b013e318233e951] [PMID: 22016015]
[12]
Maurer J, Hipp M, Schäfer C, Kölbl O. Dysphagia. Impact on quality of life after radio(chemo)therapy of head and neck cancer. Strahlenther Onkol 2011; 187(11): 744-9.
[http://dx.doi.org/10.1007/s00066-011-2275-x] [PMID: 22037655]
[13]
Erdem O, Güngörmüş Z. The effect of royal jelly on oral mucositis in patients undergoing radiotherapy and chemotherapy. Holist Nurs Pract 2014; 28(4): 242-6.
[http://dx.doi.org/10.1097/HNP.0000000000000033] [PMID: 24919094]
[14]
Lalla RV, Bowen J, Barasch A, et al. Mucositis Guidelines Leadership Group of the Multinational Association of Supportive Care in Cancer and International Society of Oral Oncology (MASCC/ISOO). MASCC/ISOO clinical practice guidelines for the management of mucositis secondary to cancer therapy. Cancer 2014; 120(10): 1453-61.
[http://dx.doi.org/10.1002/cncr.28592] [PMID: 24615748]
[15]
Kashiwazaki H, Matsushita T, Sugita J, et al. Professional oral health care reduces oral mucositis and febrile neutropenia in patients treated with allogeneic bone marrow transplantation. Support Care Cancer 2012; 20(2): 367-73.
[http://dx.doi.org/10.1007/s00520-011-1116-x] [PMID: 21328006]
[16]
Plevová P. Prevention and treatment of chemotherapy- and radiotherapy-induced oral mucositis: a review. Oral Oncol 1999; 35(5): 453-70.
[http://dx.doi.org/10.1016/S1368-8375(99)00033-0] [PMID: 10694945]
[17]
Peterson DE, Bensadoun RJ, Roila F. ESMO Guidelines Working Group. Management of oral and gastrointestinal mucositis: ESMO Clinical Practice Guidelines. Ann Oncol 2011; 22(Suppl. 6): vi78-84.
[http://dx.doi.org/10.1093/annonc/mdr391] [PMID: 21908510]
[18]
Luo DH, Hong MH, Guo L, Cao KJ, Deng MQ, Mo HY. [Analysis of oral mucositis risk factors during radiotherapy for nasopharyngeal carcinoma patients and establishment of a discriminant model Chin J Cancer 2005; 24(7): 850-4.
[PMID: 16004814]
[19]
Eilers J, Million R. Prevention and management of oral mucositis in patients with cancer. Semin Oncol Nurs 2007; 23(3): 201-12.
[http://dx.doi.org/10.1016/j.soncn.2007.05.005] [PMID: 17693347]
[20]
Elting LS, Cooksley CD, Chambers MS, Garden AS. Risk, outcomes, and costs of radiation-induced oral mucositis among patients with head-and-neck malignancies. Int J Radiat Oncol Biol Phys 2007; 68(4): 1110-20.
[http://dx.doi.org/10.1016/j.ijrobp.2007.01.053] [PMID: 17398022]
[21]
Mazzola R, Fiorentino A, Ricchetti F, Gregucci F, Corradini S, Alongi F. An update on radiation therapy in head and neck cancers. Expert Rev Anticancer Ther 2018; 18(4): 359-64.
[http://dx.doi.org/10.1080/14737140.2018.1446832] [PMID: 29485913]
[22]
De Sanctis V, Bossi P, Sanguineti G, et al. Mucositis in head and neck cancer patients treated with radiotherapy and systemic therapies: Literature review and consensus statements. Crit Rev Oncol Hematol 2016; 100: 147-66.
[http://dx.doi.org/10.1016/j.critrevonc.2016.01.010] [PMID: 26947812]
[23]
Cox JD, Stetz J, Pajak TF. Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC). Int J Radiat Oncol Biol Phys 1995; 31(5): 1341-6.
[http://dx.doi.org/10.1016/0360-3016(95)00060-C] [PMID: 7713792]
[24]
Chen SC, Lai YH, Huang BS, Lin CY, Fan KH, Chang JT. Changes and predictors of radiation-induced oral mucositis in patients with oral cavity cancer during active treatment. Eur J Oncol Nurs 2015; 19(3): 214-9.
[http://dx.doi.org/10.1016/j.ejon.2014.12.001] [PMID: 25586214]
[25]
YukariSudoh. Elaine Elliott, CahoonPeter, GernerGing, KuoWang. Tricyclic antidepressants as longactinglocal anesthetics. Pain 2003; 103: 49-55.
[26]
Sio TT, Le-Rademacher JG, Leenstra JL, et al. Effect of Doxepin Mouthwash or Diphenhydramine-Lidocaine-Antacid Mouthwash vs Placebo on Radiotherapy-Related Oral Mucositis Pain: The Alliance A221304 Randomized Clinical Trial JAMA 2019; 321: 1481-90.
[27]
Jayakrishnan R, Chang K, Ugurluer G, Miller RC, Sio TT. Doxepin for Radiation Therapy-Induced Mucositis Pain in the Treatment of Oral Cancers. Oncol Rev 2015; 9(1): 290.
[http://dx.doi.org/10.4081/oncol.2015.290] [PMID: 26779314]
[28]
Sarvizadeh M, Hemati S, Meidani M, Ashouri M, Roayaei M, Shahsanai A. Morphine mouthwash for the management of oral mucositis in patients with head and neck cancer. Adv Biomed Res 2015; 4: 44.
[http://dx.doi.org/10.4103/2277-9175.151254] [PMID: 25789270]
[29]
Dutta K, Garg R. Morphine mouthwash in oral mucositis: A mini review Palliat Med Hosp Care Open 2016; 2: 26-9.
[30]
Quinn B, Potting CM, Stone R, et al. Guidelines for the assessment of oral mucositis in adult chemotherapy, radiotherapy and haematopoietic stem cell transplant patients. Eur J Cancer 2008; 44(1): 61-72.
[http://dx.doi.org/10.1016/j.ejca.2007.09.014] [PMID: 17988858]
[31]
Lalla RV, Schubert MM, Bensadoun RJ, Keefe D. Anti-inflammatory agents in the management of alimentary mucositis. Support Care Cancer 2006; 14(6): 558-65.
[http://dx.doi.org/10.1007/s00520-006-0050-9] [PMID: 16565821]
[32]
Sheibani KM, Mafi AR, Moghaddam S, Taslimi F, Amiran A, Ameri A. Efficacy of benzydamine oral rinse in prevention and management of radiation-induced oral mucositis: A double-blind placebo-controlled randomized clinical trial. Asia Pac J Clin Oncol 2015; 11(1): 22-7.
[http://dx.doi.org/10.1111/ajco.12288] [PMID: 25471468]
[33]
Sahebjamee M, Mansourian A, Hajimirzamohammad M, et al. Comparative Efficacy of Aloe vera and Benzydamine Mouthwashes on Radiation-induced Oral Mucositis: A Triple-blind, Randomised, Controlled Clinical Trial. Oral Health Prev Dent 2015; 13(4): 309-15.
[PMID: 25431805]
[34]
Chitapanarux I, Tungkasamit T, Petsuksiri J, et al. Randomized control trial of benzydamine HCl versus sodium bicarbonate for prophylaxis of concurrent chemoradiation-induced oral mucositis. Support Care Cancer 2018; 26(3): 879-86.
[http://dx.doi.org/10.1007/s00520-017-3904-4] [PMID: 28942587]
[35]
Rastogi M, Khurana R, Revannasiddaiah S, et al. Role of benzydamine hydrochloride in the prevention of oral mucositis in head and neck cancer patients treated with radiotherapy (>50 Gy) with or without chemotherapy. Support Care Cancer 2017; 25(5): 1439-43.
[http://dx.doi.org/10.1007/s00520-016-3548-9] [PMID: 27987094]
[36]
Ariyawardana A, Cheng KKF, Kandwal A, et al. Mucositis Study Group of the Multinational Association of Supportive Care in Cancer/International Society for Oral Oncology (MASCC/ISOO). Systematic review of anti-inflammatory agents for the management of oral mucositis in cancer patients and clinical practice guidelines. Support Care Cancer 2019; 27(10): 3985-95.
[http://dx.doi.org/10.1007/s00520-019-04888-w] [PMID: 31286230]
[37]
Miller RC, Le-Rademacher J. A Phase III, Randomized Double-Blind Study of Doxepin Rinse versus Magic Mouthwash versus Placebo in the Treatment of Acute Oral Mucositis Pain in Patients Receiving Head and Neck Radiotherapy with or without Chemotherapy 2016; 96: 938.
[38]
Konishi M, Verdonschot RG, Shimabukuro K, Nakamoto T, Fujita M, Kakimoto N. The effectiveness of mouthwashes in alleviating radiation-induced oral mucositis in head and neck cancer patients: a systematic review. Oral Radiol 2019; 35(3): 207-23.
[http://dx.doi.org/10.1007/s11282-018-0361-9] [PMID: 30535943]
[39]
Kakoei S, Pardakhty A, Hashemipour MA, Larizadeh H, Kalantari B, Tahmasebi E. Comparison the Pain Relief of Amitriptyline Mouthwash with Benzydamine in Oral Mucositis. J Dent (Shiraz) 2018; 19(1): 34-40.
[PMID: 29492414]
[40]
Roldan CJ, Nouri K, Chai T, Huh B. Methylene Blue for the Treatment of Intractable Pain Associated with Oral Mucositis. Pain Pract 2017; 17(8): 1115-21.
[http://dx.doi.org/10.1111/papr.12566] [PMID: 28226414]
[41]
Chaitanya B, Pai KM, Yathiraj PH, Fernandes D, Chhaparwal Y. Rebamipide gargle in preventive management of chemo-radiotherapy induced oral mucositis. Oral Oncol 2017; 72: 179-82.
[http://dx.doi.org/10.1016/j.oraloncology.2017.07.024] [PMID: 28797456]
[42]
Akagi S, Fujiwara T, Nishida M, et al. The effectiveness of rebamipide mouthwash therapy for radiotherapy and chemoradiotherapy-induced oral mucositis in patients with head and neck cancer: a systematic review and meta-analysis. J Pharm Health Care Sci 2019; 5: 16.
[http://dx.doi.org/10.1186/s40780-019-0146-2] [PMID: 31367460]
[43]
Yamashita T, Araki K, Tomifuji M, Kamide D, Tanaka Y, Shiotani A. A traditional Japanese medicine--Hangeshashinto (TJ-14)--alleviates chemoradiation-induced mucositis and improves rates of treatment completion. Support Care Cancer 2015; 23(1): 29-35.
[http://dx.doi.org/10.1007/s00520-014-2315-z] [PMID: 24943276]
[44]
Kong M, Hwang DS, Yoon SW, Kim J. The effect of clove-based herbal mouthwash on radiation-induced oral mucositis in patients with head and neck cancer: a single-blind randomized preliminary study. OncoTargets Ther 2016; 9: 4533-8.
[http://dx.doi.org/10.2147/OTT.S108769] [PMID: 27524909]
[45]
Baharvand M, Jafari S, Mortazavi H. Herbs in Oral Mucositis J ClinDiagn Res 2017; 11: 05-11.
[46]
Wang C, Wang P, Ouyang H, et al. Efficacy of Traditional Chinese Medicine in Treatment and Prophylaxis of Radiation-Induced Oral Mucositis in Patients Receiving Radiotherapy: A Randomized Controlled Trial. Integr Cancer Ther 2018; 17(2): 444-50.
[http://dx.doi.org/10.1177/1534735417725578] [PMID: 28870095]
[47]
Elyasi S, Hosseini S, Niazi Moghadam MR, Aledavood SA, Karimi G. Effect of Oral Silymarin Administration on Prevention of Radiotherapy Induced Mucositis: A Randomized, Double-Blinded, Placebo-Controlled Clinical Trial. Phytother Res 2016; 30(11): 1879-85.
[http://dx.doi.org/10.1002/ptr.5704] [PMID: 27555604]
[48]
Aghamohammadi A, Moslemi D, Akbari J, et al. The effectiveness of Zataria extract mouthwash for the management of radiation-induced oral mucositis in patients: a randomized placebo-controlled double-blind study. Clin Oral Investig 2018; 22(6): 2263-72.
[http://dx.doi.org/10.1007/s00784-017-2324-7] [PMID: 29313134]
[49]
Patil K, Guledgud MV, Kulkarni PK, Keshari D, Tayal S. Use of Curcumin Mouthrinse in Radio-Chemotherapy Induced Oral Mucositis Patients: A Pilot Study. J Clin Diagn Res 2015; 9(8): ZC59-62.
[http://dx.doi.org/10.7860/JCDR/2015/13034.6345] [PMID: 26436049]
[50]
Delavarian Z, Pakfetrat A, Ghazi A, et al. Oral administration of nanomicelle curcumin in the prevention of radiotherapy-induced mucositis in head and neck cancers. Spec Care Dentist 2019; 39(2): 166-72.
[http://dx.doi.org/10.1111/scd.12358] [PMID: 30761565]
[51]
Normando AGC, de Menêses AG, de Toledo IP, et al. Effects of turmeric and curcumin on oral mucositis: A systematic review. Phytother Res 2019; 33(5): 1318-29.
[http://dx.doi.org/10.1002/ptr.6326] [PMID: 30838707]
[52]
JavadzadehBolouri A. Pakfetrat A, TonkaboniAetal.Preventing and Therapeutic Effect of Propolis in Radiotherapy Induced Mucositis of Head and Neck Cancers: A Triple-Blind, Randomized, Placebo-Controlled Trial. Iran J Cancer Prev 2015; 8: 4019.
[53]
Kuo CC, Wang RH, Wang HH, Li CH. Meta-analysis of randomized controlled trials of the efficacy of propolis mouthwash in cancer therapy-induced oral mucositis. Support Care Cancer 2018; 26(12): 4001-9.
[http://dx.doi.org/10.1007/s00520-018-4344-5] [PMID: 30022350]
[54]
Waśko-Grabowska A, Rzepecki P, Oborska S, et al. Efficiency of supersaturated calcium phosphate mouth rinse treatment in patients receiving high-dose melphalan or BEAM prior to autologous blood stem cell transplantation: a single-center experience. Transplant Proc 2011; 43(8): 3111-3.
[http://dx.doi.org/10.1016/j.transproceed.2011.08.053] [PMID: 21996239]
[55]
Papas AS, Clark RE, Martuscelli G, O’Loughlin KT, Johansen E, Miller KB. A prospective, randomized trial for the prevention of mucositis in patients undergoing hematopoietic stem cell transplantation. Bone Marrow Transplant 2003; 31(8): 705-12.
[http://dx.doi.org/10.1038/sj.bmt.1703870] [PMID: 12692611]
[56]
Kiprian D, Jarzabski A, Kawecki A. Evaluation of efficacy of Caphosol in prevention and alleviation of acute side effects in patients treated with radiotherapy for head and neck cancers. Contemp Oncol (Pozn) 2016; 20(5): 389-93.
[http://dx.doi.org/10.5114/wo.2016.64600] [PMID: 28373821]
[57]
Jang H, Lee H. Meta-analysis of pain relief effects by laser irradiation on joint areas. Photomed Laser Surg 2012; 30(8): 405-17.
[http://dx.doi.org/10.1089/pho.2012.3240] [PMID: 22747309]
[58]
Oton-Leite AF, Silva GB, Morais MO, et al. Effect of low-level laser therapy on chemoradiotherapy-induced oral mucositis and salivary inflammatory mediators in head and neck cancer patients. Lasers Surg Med 2015; 47(4): 296-305.
[http://dx.doi.org/10.1002/lsm.22349] [PMID: 25824475]
[59]
Gautam AP, Fernandes DJ, Vidyasagar MS, Maiya AG, Guddattu V. Low level laser therapy against radiation induced oral mucositis in elderly head and neck cancer patients-a randomized placebo controlled trial. J Photochem Photobiol B 2015; 144: 51-6.
[http://dx.doi.org/10.1016/j.jphotobiol.2015.01.011] [PMID: 25704314]
[60]
Zecha JA, Raber-Durlacher JE, Nair RG, et al. Low-level laser therapy/photobiomodulation in the management of side effects of chemoradiation therapy in head and neck cancer: part 2: proposed applications and treatment protocols. Support Care Cancer 2016; 24(6): 2793-805.
[http://dx.doi.org/10.1007/s00520-016-3153-y] [PMID: 26984249]
[61]
Zecha JA, Raber-Durlacher JE, Nair RG, et al. Low level laser therapy/photobiomodulation in the management of side effects of chemoradiation therapy in head and neck cancer: part 1: mechanisms of action, dosimetric, and safety considerations. Support Care Cancer 2016; 24(6): 2781-92.
[http://dx.doi.org/10.1007/s00520-016-3152-z] [PMID: 26984240]
[62]
Spivakovsky S. Low level laser therapy may reduce risk of oral mucositis. Evid Based Dent 2015; 16(2): 49.
[http://dx.doi.org/10.1038/sj.ebd.6401095] [PMID: 26114788]
[63]
Peng H, Chen BB, Chen L, et al. A network meta-analysis in comparing prophylactic treatments of radiotherapy-induced oral mucositis for patients with head and neck cancers receiving radiotherapy. Oral Oncol 2017; 75: 89-94.
[http://dx.doi.org/10.1016/j.oraloncology.2017.11.001] [PMID: 29224830]
[64]
González-Arriagada WA, Ramos LMA, Andrade MAC, Lopes MA. Efficacy of low-level laser therapy as an auxiliary tool for management of acute side effects of head and neck radiotherapy. J Cosmet Laser Ther 2018; 20(2): 117-22.
[http://dx.doi.org/10.1080/14764172.2017.1376097] [PMID: 29020483]
[65]
Soares RG, Farias LC. da Silva Menezes ASet al. Treatment of mucositis with combined 660- and 808-nm-wave length low-level laser therapy reduced mucositis grade, pain, and use of analgesics: a parallel, single-blind, two-arm controlled study. Lasers Med Sci 2018; 33: 1813-9.
[http://dx.doi.org/10.1007/s10103-018-2549-y] [PMID: 29948456]
[66]
Martins AFL, Nogueira TE, Morais MO, et al. Effect of photobiomodulation on the severity of oral mucositis and molecular changes in head and neck cancer patients undergoing radiotherapy: a study protocol for a cost-effectiveness randomized clinical trial. Trials 2019; 20(1): 97.
[http://dx.doi.org/10.1186/s13063-019-3196-8] [PMID: 30709370]
[67]
Marín-Conde F, Castellanos-Cosano L, Pachón-Ibañez J, Serrera-Figallo MA, Gutiérrez-Pérez JL, Torres-Lagares D. Photobiomodulation with low-level laser therapy reduces oral mucositis caused by head and neck radio-chemotherapy: prospective randomized controlled trial. Int J Oral Maxillofac Surg 2019; 48(7): 917-23.
[http://dx.doi.org/10.1016/j.ijom.2018.12.006] [PMID: 30591391]
[68]
Bourbonne V, Otz J. Radiotherapy mucositis in head and neck cancer: prevention by low-energy surface laser BMJ Support Palliat Care 2019 Sep 16; bmjspcare-2019-001851
[69]
Peralta-Mamani M, da Silva BM, da Silva Pinto AC, et al. Low-level laser therapy dosimetry most used for oral mucositis due to radiotherapy for head and neck cancer: a systematic review and meta-analysis. Crit Rev Oncol Hematol 2019; 138: 14-23.
[http://dx.doi.org/10.1016/j.critrevonc.2019.03.009] [PMID: 31092370]
[70]
Anschau F, Webster J, Capra MEZ, de Azeredo da Silva ALF, Stein AT. Efficacy of low-level laser for treatment of cancer oral mucositis: a systematic review and meta-analysis. Lasers Med Sci 2019; 34(6): 1053-62.
[http://dx.doi.org/10.1007/s10103-019-02722-7] [PMID: 30729351]
[71]
Mogensen S, Treldal C. SveinsdottirKet al. A novel lozenge containing bupivacaine as topical alleviation of oral mucositis pain in patientswith head and neck cancer: a pilot study. Pain Rep 2016; 1e571
[http://dx.doi.org/10.1097/PR9.0000000000000571] [PMID: 29392194]
[72]
Mogensen S, Treldal C. KristensenCAetal.Effect of bupivacaine lozenges on oral mucositis pain: a randomized controlled multicenterphase II study. Pain Rep 2017; 2e619
[http://dx.doi.org/10.1097/PR9.0000000000000619] [PMID: 29392234]
[73]
Abo Enin HA, El Nabarawy NA, Elmonem RA. Treatment of Radiation-Induced Oral Mucositis Using a Novel Accepted Taste of Prolonged Release Mucoadhesive Bi-medicated Double-Layer Buccal Films. AAPS PharmSciTech 2017; 18(2): 563-75.
[http://dx.doi.org/10.1208/s12249-016-0533-z] [PMID: 27138037]
[74]
Mazzola R, Ricchetti F, Fiorentino A, et al. Fentanyl pectin nasal spray for painful mucositis in head and neck cancers during intensity-modulated radiation therapy with or without chemotherapy. Clin Transl Oncol 2017; 19(5): 593-8.
[http://dx.doi.org/10.1007/s12094-016-1570-5] [PMID: 27853984]
[75]
Hu W, Chen L, Wang C, et al. Standardized nursing and therapeutic effect of oxycontin on oral mucosal pain in nasopharyngeal carcinoma patients. J Cancer Res Ther 2018; 14(7): 1594-9.
[http://dx.doi.org/10.4103/jcrt.JCRT_551_18] [PMID: 30589045]
[76]
Ghalayani P, Emami H, Pakravan F, Nasr Isfahani M. Comparison of triamcinolone acetonide mucoadhesive film with licorice mucoadhesive film on radiotherapy-induced oral mucositis: A randomized double-blinded clinical trial. Asia Pac J Clin Oncol 2017; 13(2): e48-56.
[http://dx.doi.org/10.1111/ajco.12295] [PMID: 25347930]
[77]
Pakravan F, Ghalayani P, Emami H, Isfahani MN, Noorshargh P. A novel formulation for radiotherapy-induced oral mucositis: Triamcinolone acetonide mucoadhesive film. J Res Med Sci 2019; 24: 63.
[http://dx.doi.org/10.4103/jrms.JRMS_456_18] [PMID: 31523249]
[78]
Milazzo-Kiedaisch CA, Itano J, Dutta PR. Role of Gabapentin in Managing Mucositis Pain in Patients Undergoing Radiation Therapy to the Head and Neck. Clin J Oncol Nurs 2016; 20(6): 623-8.
[http://dx.doi.org/10.1188/16.CJON.623-628] [PMID: 27857262]
[79]
Dooley DJ, Taylor CP, Donevan S, Feltner D. Ca2+ channel alpha2delta ligands: novel modulators of neurotransmission. Trends Pharmacol Sci 2007; 28(2): 75-82.
[http://dx.doi.org/10.1016/j.tips.2006.12.006] [PMID: 17222465]
[80]
Kondaveeti SS, C v D, John C, M M, S R. Therapeutic Benefit of Placentrex in the Management of Acute Chemo Radiation Induced Mucositis in Oral Cancer Patients. Asian Pac J Cancer Prev 2018; 19(11): 3099-103.
[http://dx.doi.org/10.31557/APJCP.2018.19.11.3099] [PMID: 30486548]
[81]
Singh DT, Padshetty S, Shreen S, Begum N, Vishwakarma SK, Khan AA. Injection of placentrex in the management of oral submucous fibrosis. Int J Mod Sci Eng Technol 2015; 2: 23-30.
[82]
Nalamachu S, Wortmann R. Role of indomethacin in acute pain and inflammation management: a review of the literature. Postgrad Med 2014; 126(4): 92-7.
[http://dx.doi.org/10.3810/pgm.2014.07.2787] [PMID: 25141247]
[83]
Momo K, Nagaoka H, Kizawa Y, et al. Assessment of indomethacin oral spray for the treatment of oropharyngeal mucositis-induced pain during anticancer therapy. Support Care Cancer 2017; 25(10): 2997-3000.
[http://dx.doi.org/10.1007/s00520-017-3817-2] [PMID: 28711976]
[84]
Kubota K, Kobayashi W, Sakaki H, et al. Professional oral health care reduces oral mucositis pain in patients treated by superselective intra-arterial chemotherapy concurrent with radiotherapy for oral cancer. Support Care Cancer 2015; 23(11): 3323-9.
[http://dx.doi.org/10.1007/s00520-015-2774-x] [PMID: 25987235]
[85]
Hong CHL, Gueiros LA, Fulton JS, et al. Mucositis Study Group of the Multinational Association of Supportive Care in Cancer/International Society for Oral Oncology (MASCC/ISOO). Systematic review of basic oral care for the management of oral mucositis in cancer patients and clinical practice guidelines. Support Care Cancer 2019; 27(10): 3949-67.
[http://dx.doi.org/10.1007/s00520-019-04848-4] [PMID: 31286232]
[86]
Kawashita Y, Koyama Y, Kurita H, et al. Effectiveness of a comprehensive oral management protocol for the prevention of severe oral mucositis in patients receiving radiotherapy with or without chemotherapy for oral cancer: a multicentre, phase II, randomized controlled trial. Int J Oral Maxillofac Surg 2019; 48(7): 857-64.
[http://dx.doi.org/10.1016/j.ijom.2018.10.010] [PMID: 30611598]
[87]
Dale CM, Smith O, Burry L, Rose L. Prevalence and predictors of difficulty accessing the mouths of intubated critically ill adults to deliver oral care: An observational study. Int J Nurs Stud 2018; 80: 36-40.
[http://dx.doi.org/10.1016/j.ijnurstu.2017.12.009] [PMID: 29353710]
[88]
Al-Waili NS, Saloom KY. Effects of topical honey on post-operative wound infections due to gram positive and gram negative bacteria following caesarean sections and hysterectomies. Eur J Med Res 1999; 4(3): 126-30.
[PMID: 10085281]
[89]
Samdariya S, Lewis S, Kauser H, Ahmed I, Kumar D. A Randomized Controlled Trial Evaluating the Role of Honey in Reducing Pain Due to Radiation Induced Mucositis in Head and Neck Cancer Patients. Indian J Palliat Care 2015; 21(3): 268-73.
[http://dx.doi.org/10.4103/0973-1075.164892] [PMID: 26600693]
[90]
Cho HK, Jeong YM, Lee HS, Lee YJ, Hwang SH. Effects of honey on oral mucositis in patients with head and neck cancer: A meta-analysis. Laryngoscope 2015; 125(9): 2085-92.
[http://dx.doi.org/10.1002/lary.25233] [PMID: 25778825]
[91]
Bahramnezhad F, Dehghan Nayeri N, Bassampour SS, Khajeh M, Asgari P. Honey and Radiation-Induced Stomatitis in Patients With Head and Neck Cancer. Iran Red Crescent Med J 2015; 17(10)e19256
[http://dx.doi.org/10.5812/ircmj.19256] [PMID: 26568850]
[92]
Jayalekshmi JL, Lakshmi R, Mukerji A. Honey on oral mucositis: A Randomized controlled trial. Gulf J Oncolog 2016; 1(20): 30-7.
[PMID: 27050177]
[93]
Co JL, Mejia MB, Que JC, Dizon JM. Effectiveness of honey on radiation-induced oral mucositis, time to mucositis, weight loss, and treatment interruptions among patients with head and neck malignancies: A meta-analysis and systematic review of literature. Head Neck 2016; 38(7): 1119-28.
[http://dx.doi.org/10.1002/hed.24431] [PMID: 27028991]
[94]
Xu JL, Xia R, Sun ZH, et al. Effects of honey use on the management of radio/chemotherapy-induced mucositis: a meta-analysis of randomized controlled trials. Int J Oral Maxillofac Surg 2016; 45(12): 1618-25.
[http://dx.doi.org/10.1016/j.ijom.2016.04.023] [PMID: 27600797]
[95]
Alvi ZA, Mahmood A, Rasool S. Role of honey in prevention of radiation induced mucositis in head and neck cancer. Pak Armed Forces Med J 2017; 63: 379-83.
[96]
Amanat A, Ahmed A, Kazmi A, Aziz B. The Effect of Honey on Radiation-induced Oral Mucositis in Head and Neck Cancer Patients. Indian J Palliat Care 2017; 23(3): 317-20.
[http://dx.doi.org/10.4103/IJPC.IJPC_146_16] [PMID: 28827938]
[97]
Bansal A, Ghoshal S, Yadav BK. Exploring the role of “glycerine plus honey” in delaying chemoradiation induced oral mucositis in head and neck cancers. Int J Cancer TherOncol 2017; 5: 1-7.
[98]
Rao S, Hegde SK. Honey Mitigates Radiation Induced Oral Mucositis in Head and Neck Cancer Patients without Affecting the Tumor Response Foods 2017; 6: 77.
[99]
Charalambous M, Raftopoulos V, Paikousis L, et al. The effect of the use of thyme honey in minimizing radiation - induced oral mucositis in head and neck cancer patients: A randomized controlled trial. Eur J Oncol Nurs 2018; 34: 89-97.
[http://dx.doi.org/10.1016/j.ejon.2018.04.003] [PMID: 29784145]
[100]
Münstedt K, Momm F, Hübner J. Honey in the management of side effects of radiotherapy- or radio/chemotherapy-induced oral mucositis. A systematic review. Complement Ther Clin Pract 2019; 34: 145-52.
[http://dx.doi.org/10.1016/j.ctcp.2018.11.016] [PMID: 30712719]
[101]
Yang C, Gong G, Jin E, et al. Topical application of honey in the management of chemo/radiotherapy-induced oral mucositis: A systematic review and network meta-analysis. Int J Nurs Stud 2019; 89: 80-7.
[http://dx.doi.org/10.1016/j.ijnurstu.2018.08.007] [PMID: 30352321]
[102]
Kotian SR, Bhat KMR, Padma D, Pai KSR. Influence of traditional medicines on the activity of keratinocytes in wound healing: an in-vitro study. Anat Cell Biol 2019; 52(3): 324-32.
[http://dx.doi.org/10.5115/acb.19.009] [PMID: 31598362]
[103]
Najafi S, Koujan SE, Manifar S, Kharazifard MJ, Kidi S, Hajheidary S. Preventive Effect of Glycyrrhiza Glabra Extract on Oral Mucositis in Patients Under Head and Neck Radiotherapy: A Randomized Clinical Trial. J Dent (Tehran) 2017; 14(5): 267-74.
[PMID: 29296112]
[104]
Harada K, Ferdous T, Horinaga D, et al. Efficacy of elemental diet on prevention for chemoradiotherapy-induced oral mucositis in patients with oral squamous cell carcinoma. Support Care Cancer 2016; 24(2): 953-9.
[http://dx.doi.org/10.1007/s00520-015-2866-7] [PMID: 26248650]
[105]
Demir Doğan M, Can G, Meral R. DemirDoğan M. Effectiveness of Black Mulberry Molasses in Prevention of Radiotherapy-Induced Oral Mucositis: A Randomized Controlled Study in Head and Neck Cancer Patients. J Altern Complement Med 2017; 23(12): 971-9.
[http://dx.doi.org/10.1089/acm.2016.0425] [PMID: 28677999]
[106]
Wei J, Wu J. Effects of Early Nutritional Intervention on Oral Mucositis in Patients with Radiotherapy for Head and Neck Cancer QJM 2020; 113: 37-42.
[107]
Chaitanya NC, Muthukrishnan A, Babu DBG, et al. Role of Vitamin E and Vitamin A in Oral Mucositis Induced by Cancer Chemo/Radiotherapy- A Meta-analysis. J Clin Diagn Res 2017; 11(5): ZE06-9.
[http://dx.doi.org/10.7860/JCDR/2017/26845.9905] [PMID: 28658926]
[108]
Sun H, Zhu X, Li D, Cheng T. Effects of a compound vitamin B mixture in combination with GeneTime® on radiation-induced oral mucositis. J Int Med Res 2019; 47(5): 2126-34.
[http://dx.doi.org/10.1177/0300060519831171] [PMID: 30938568]
[109]
Prasad AS. Zinc in human health: effect of zinc on immune cells. Mol Med 2008; 14(5-6): 353-7.
[http://dx.doi.org/10.2119/2008-00033.Prasad] [PMID: 18385818]
[110]
de Menêses AG, Normando AGC, Porto de Toledo I, Reis PED, Guerra ENS. Effects of oral supplementation in the management of oral mucositis in cancer patients: A meta-analysis of randomized clinical trials. J Oral Pathol Med 2020; 49(2): 117-25.
[http://dx.doi.org/10.1111/jop.12901] [PMID: 31172573]
[111]
Chaitanya NC, Shugufta K, Suvarna C, et al. A Meta-Analysis on the Efficacy of Zinc in Oral Mucositis during Cancer Chemo and/or Radiotherapy-An Evidence-Based Approach. J Nutr Sci Vitaminol (Tokyo) 2019; 65(2): 184-91.
[http://dx.doi.org/10.3177/jnsv.65.184] [PMID: 31061288]
[112]
Sakagami M, Ikeda M, Tomita H, et al. A zinc-containing compound, Polaprezinc, is effective for patients with taste disorders: randomized, double-blind, placebo-controlled, multi-center study. Acta Otolaryngol 2009; 129(10): 1115-20.
[http://dx.doi.org/10.1080/00016480802552550] [PMID: 19037756]
[113]
Doi H, Fujiwara M, Suzuki H, et al. Polaprezinc reduces the severity of radiation-induced mucositis in head and neck cancer patients. Mol Clin Oncol 2015; 3(2): 381-6.
[http://dx.doi.org/10.3892/mco.2014.479] [PMID: 25798271]
[114]
Tsujimoto T, Yamamoto Y, Wasa M, et al. L-glutamine decreases the severity of mucositis induced by chemoradiotherapy in patients with locally advanced head and neck cancer: a double-blind, randomized, placebo-controlled trial. Oncol Rep 2015; 33(1): 33-9.
[http://dx.doi.org/10.3892/or.2014.3564] [PMID: 25351453]
[115]
Pattanayak L, Panda N, Dash MK, Mohanty S, Samantaray S. Management of Chemoradiation-Induced Mucositis in Head and Neck Cancers With Oral Glutamine. J Glob Oncol 2016; 2(4): 200-6.
[http://dx.doi.org/10.1200/JGO.2015.000786] [PMID: 28717702]
[116]
Sayles C, Hickerson SC, Bhat RR, Hall J, Garey KW, Trivedi MV. Oral Glutamine in Preventing Treatment-Related Mucositis in Adult Patients With Cancer: A Systematic Review. Nutr Clin Pract 2016; 31(2): 171-9.
[http://dx.doi.org/10.1177/0884533615611857] [PMID: 26507188]
[117]
Leung HW, Chan AL. Glutamine in Alleviation of Radiation-Induced Severe Oral Mucositis: A Meta-Analysis. Nutr Cancer 2016; 68(5): 734-42.
[http://dx.doi.org/10.1080/01635581.2016.1159700] [PMID: 27045857]
[118]
Lopez-Vaquero D, Gutierrez-Bayard L, Rodriguez-Ruiz JA, Saldaña-Valderas M, Infante-Cossio P. Double-blind randomized study of oral glutamine on the management of radio/chemotherapy-induced mucositis and dermatitis in head and neck cancer. Mol Clin Oncol 2017; 6(6): 931-6.
[http://dx.doi.org/10.3892/mco.2017.1238] [PMID: 28588793]
[119]
Müge AKMANSU, Sevilay İREN, Gül GÜNTÜRKÜN. The Effect of Using Oral Glutamine on the Side Effect of Mucositis in Patients with Head and Neck Cancer Who Are Receiving Chemoradiotherapy: Retrospective Evaluation with Clinical and Immunological Parameters. Turk J Oncol 2018; 33: 115-21.
[120]
Pathak S, Soni TP, Sharma LM, Patni N, Gupta AK. A Randomized Controlled Trial to Evaluate the Role and Efficacy of Oral Glutamine in the Treatment of Chemo-radiotherapy-induced Oral Mucositis and Dysphagia in Patients with Oropharynx and Larynx Carcinoma. Cureus 2019; 11(6)e4855
[http://dx.doi.org/10.7759/cureus.4855] [PMID: 31410338]
[121]
Yarom N, Hovan A, Bossi P, et al. Mucositis Study Group of the Multinational Association of Supportive Care in Cancer/International Society of Oral Oncology (MASCC/ISOO). Systematic review of natural and miscellaneous agents for the management of oral mucositis in cancer patients and clinical practice guidelines-part 1: vitamins, minerals, and nutritional supplements. Support Care Cancer 2019; 27(10): 3997-4010.
[http://dx.doi.org/10.1007/s00520-019-04887-x] [PMID: 31286229]
[122]
Chattopadhyay S, Saha A, Azam M, Mukherjee A, Sur PK. Role of oral glutamine in alleviation and prevention of radiation-induced oral mucositis: A prospective randomized study. South Asian J Cancer 2014; 3(1): 8-12.
[http://dx.doi.org/10.4103/2278-330X.126501] [PMID: 24665438]
[123]
Hamstra DA, Lee KC, Eisbruch A, et al. Double-blind placebo-controlled multicenter phase II trial to evaluate D-methionine in preventing/reducing oral mucositis induced by radiation and chemotherapy for head and neck cancer. Head Neck 2018; 40(7): 1375-88.
[http://dx.doi.org/10.1002/hed.25115] [PMID: 29473247]
[124]
Blijlevens N, Sonis S. Palifermin (recombinant keratinocyte growth factor-1): a pleiotropic growth factor with multiple biological activities in preventing chemotherapy- and radiotherapy-induced mucositis. Ann Oncol 2007; 18(5): 817-26.
[http://dx.doi.org/10.1093/annonc/mdl332] [PMID: 17030544]
[125]
Le QT, Kim HE, Schneider CJ, et al. Palifermin reduces severe mucositis in definitive chemoradiotherapy of locally advanced head and neck cancer: a randomized, placebo-controlled study. J Clin Oncol 2011; 29(20): 2808-14.
[http://dx.doi.org/10.1200/JCO.2010.32.4095] [PMID: 21670453]
[126]
Henke M, Alfonsi M, Foa P, et al. Palifermin decreases severe oral mucositis of patients undergoing postoperative radiochemotherapy for head and neck cancer: a randomized, placebo-controlled trial. J Clin Oncol 2011; 29(20): 2815-20.
[http://dx.doi.org/10.1200/JCO.2010.32.4103] [PMID: 21670447]
[127]
Riley P, Glenny AM, Worthington HV, et al. Interventions for preventing oral mucositis in patients with cancer receiving treatment: cytokines and growth factors. Cochrane Database Syst Rev 2017; 11CD011990
[http://dx.doi.org/10.1002/14651858.CD011990.pub2] [PMID: 29181845]
[128]
Liang G, Du W, Ke Q, Huang B, Yang J. The effects of recombinant human granulocyte colony-stimulating factor mouthwash on radiotherapy-induced oral mucositis in locally advanced nasopharyngeal carcinoma patients. Adv Clin Exp Med 2017; 26(3): 409-13.
[http://dx.doi.org/10.17219/acem/61913] [PMID: 28791814]
[129]
Bonfili P, Gravina GL, Marampon F, et al. Oral Platelet Gel Supernatant Plus Supportive Medical Treatment Versus Supportive Medical Treatment in the Management of Radiation-induced Oral Mucositis: A Matched Explorative Active Control Trial by Propensity Analysis. Am J Clin Oncol 2017; 40(4): 336-41.
[http://dx.doi.org/10.1097/COC.0000000000000177] [PMID: 25599319]
[130]
Bai XH, Chen ZM, Ma LH, He Z, Li G. Prevention effect of low-temperature atomization inhalation for radiation induced oral mucositis in patients with head and neck cancer undergoing radiotherapy. Cancer Manag Res 2019; 11: 4327-33.
[http://dx.doi.org/10.2147/CMAR.S206921] [PMID: 31190997]
[131]
Chang H, Yi W, Wang X, et al. Effectiveness and safety of different amifostine regimens: Preliminary results of a phase II multicenter randomized controlled trial. Chin J Cancer Res 2018; 30(3): 307-14.
[http://dx.doi.org/10.21147/j.issn.1000-9604.2018.03.03] [PMID: 30046225]
[132]
Kanagalingam J, Chopra A, Hong MH, Ibrahim W, Villalon A, Lin JC. Povidone-iodine for the management of oral mucositis during cancer therapy. Oncol Rev 2017; 11(2): 341.
[http://dx.doi.org/10.4081/oncol.2017.341] [PMID: 28959380]
[133]
Onseng K, Johns NP, Khuayjarernpanishk T, et al. Beneficial Effects of Adjuvant Melatonin in Minimizing Oral Mucositis Complications in Head and Neck Cancer Patients Receiving Concurrent Chemoradiation. J Altern Complement Med 2017; 23(12): 957-63.
[http://dx.doi.org/10.1089/acm.2017.0081] [PMID: 28657801]
[134]
Anderson CM, Sonis ST, Lee CM, et al. Phase 1b/2a Trial of the Superoxide Dismutase Mimetic GC4419 to Reduce Chemoradiotherapy-Induced Oral Mucositis in Patients With Oral Cavity or Oropharyngeal Carcinoma. Int J Radiat Oncol Biol Phys 2018; 100(2): 427-35.
[http://dx.doi.org/10.1016/j.ijrobp.2017.10.019] [PMID: 29174131]

Rights & Permissions Print Cite
Article Metrics
34
© 2024 Bentham Science Publishers | Privacy Policy